Predicting Mortality Through High Polyclonal Free Light Chain Levels

By Mayo Clinic Laboratories • June 12, 2012

Share this:

Vincent Rajkumar, M.D., Professor of Medicine in the Division of Hematology at Mayo Clinic, illuminates the results of an article appearing in the June 2012 issue of Mayo Clinic Proceedings. The article discusses an Olmsted County population-based study where detection of high polyclonal free light chain levels can predict mortality outcomes across multiple conditions.

Mayo Clinic Laboratories

This post was authored by the Marketing Team at Mayo Clinic Laboratories.